BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38451874)

  • 1. Peroxisome proliferator-activated receptors and placental function in women with polycystic ovary syndrome.
    Silva A; Motta A
    Reproduction; 2024 May; 167(5):. PubMed ID: 38451874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental STAT3 signaling is activated in women with polycystic ovary syndrome.
    Maliqueo M; Sundström Poromaa I; Vanky E; Fornes R; Benrick A; Åkerud H; Stridsklev S; Labrie F; Jansson T; Stener-Victorin E
    Hum Reprod; 2015 Mar; 30(3):692-700. PubMed ID: 25609240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic ovary syndrome and risk of adverse pregnancy outcomes: a registry linkage study from Massachusetts.
    Farland LV; Stern JE; Liu CL; Cabral HJ; Coddington CC; Diop H; Dukhovny D; Hwang S; Missmer SA
    Hum Reprod; 2022 Oct; 37(11):2690-2699. PubMed ID: 36149255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Narrative Review of Placental Contribution to Adverse Pregnancy Outcomes in Women With Polycystic Ovary Syndrome.
    Kelley AS; Smith YR; Padmanabhan V
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5299-5315. PubMed ID: 31393571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperandrogenism and insulin resistance-induced fetal loss: evidence for placental mitochondrial abnormalities and elevated reactive oxygen species production in pregnant rats that mimic the clinical features of polycystic ovary syndrome.
    Zhang Y; Zhao W; Xu H; Hu M; Guo X; Jia W; Liu G; Li J; Cui P; Lager S; Sferruzzi-Perri AN; Li W; Wu XK; Han Y; Brännström M; Shao LR; Billig H
    J Physiol; 2019 Aug; 597(15):3927-3950. PubMed ID: 31206177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The peroxisome proliferator-activated receptors under epigenetic control in placental metabolism and fetal development.
    Lendvai Á; Deutsch MJ; Plösch T; Ensenauer R
    Am J Physiol Endocrinol Metab; 2016 May; 310(10):E797-810. PubMed ID: 26860983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of genetic variation in peroxisome proliferator-activated receptors in the polycystic ovary syndrome (PCOS): an original case-control study followed by systematic review and meta-analysis of existing evidence.
    San-Millán JL; Escobar-Morreale HF
    Clin Endocrinol (Oxf); 2010 Mar; 72(3):383-92. PubMed ID: 19681917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition.
    Froment P; Gizard F; Defever D; Staels B; Dupont J; Monget P
    J Endocrinol; 2006 May; 189(2):199-209. PubMed ID: 16648288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptors: new players in the field of reproduction.
    Toth B; Hornung D; Scholz C; Djalali S; Friese K; Jeschke U
    Am J Reprod Immunol; 2007 Sep; 58(3):289-310. PubMed ID: 17681045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macroscopic and microscopic findings of the placenta in women with polycystic ovary syndrome.
    Palomba S; Russo T; Falbo A; Di Cello A; Tolino A; Tucci L; La Sala GB; Zullo F
    Hum Reprod; 2013 Oct; 28(10):2838-47. PubMed ID: 23756703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperandrogenism and Polycystic ovary syndrome: Effects in pregnancy and offspring development.
    Abruzzese GA; Silva AF; Velazquez ME; Ferrer MJ; Motta AB
    WIREs Mech Dis; 2022 Sep; 14(5):e1558. PubMed ID: 35475329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perfluoroalkyl Substances (PFAS) and Their Effects on the Placenta, Pregnancy, and Child Development: a Potential Mechanistic Role for Placental Peroxisome Proliferator-Activated Receptors (PPARs).
    Szilagyi JT; Avula V; Fry RC
    Curr Environ Health Rep; 2020 Sep; 7(3):222-230. PubMed ID: 32812200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies.
    Mills G; Badeghiesh A; Suarthana E; Baghlaf H; Dahan MH
    Hum Reprod; 2020 Jul; 35(7):1666-1674. PubMed ID: 32535629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome Proliferator-Activated Receptors (PPAR), fatty acids and microRNAs: Implications in women delivering low birth weight babies.
    Sundrani DP; Karkhanis AR; Joshi SR
    Syst Biol Reprod Med; 2021 Feb; 67(1):24-41. PubMed ID: 33719831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Low Grade Inflammation in Pathogenesis of PCOS.
    Rudnicka E; Suchta K; Grymowicz M; Calik-Ksepka A; Smolarczyk K; Duszewska AM; Smolarczyk R; Meczekalski B
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptors are altered in pathologies of the human placenta: gestational diabetes mellitus, intrauterine growth restriction and preeclampsia.
    Holdsworth-Carson SJ; Lim R; Mitton A; Whitehead C; Rice GE; Permezel M; Lappas M
    Placenta; 2010 Mar; 31(3):222-9. PubMed ID: 20045185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy, perinatal and childhood outcomes in women with and without polycystic ovary syndrome and metformin during pregnancy: a nationwide population-based study.
    Fornes R; Simin J; Nguyen MH; Cruz G; Crisosto N; van der Schaaf M; Engstrand L; Brusselaers N
    Reprod Biol Endocrinol; 2022 Feb; 20(1):30. PubMed ID: 35130922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Trophoblast Functions.
    Peng L; Yang H; Ye Y; Ma Z; Kuhn C; Rahmeh M; Mahner S; Makrigiannakis A; Jeschke U; von Schönfeldt V
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33406768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Peroxisome Proliferator-Activated Receptors in Polycystic Ovary Syndrome.
    Psilopatis I; Vrettou K; Nousiopoulou E; Palamaris K; Theocharis S
    J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.